Health

The Sanofi Ventures-backed vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The ultrasound imaging technology developer backed by multiple corporates has completed a series C round that brought its overall funding to $320m.

Existing investors Pfizer Ventures and Merck GHI helped the precision cancer test developer take its total funding past the $130m mark.

Amazon Climate Pledge Fund committed capital to battery recycling services provider at a reported $3.7bn post-money valuation. GCV Analytics data suggest there is a heightened interest in deals from this space and an upward pressure on valuations.

IN8Bio, a University of Alabama spinout and cancer immunotherapy developer, has pulled in $40m through its IPO.

SoftBank-backed barbershop booking service Squire raised $60m at a $750m valuation while card issuing platform developer Lithic was valued at $800m in a round featuring Exor.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University of Toronto-linked Deep Genomics has picked up $180m in its series C round led by SoftBank Vision Fund 2.

Rakuten and SBI have returned to chip into the precision immunotherapy developer’s series D round, which was led by General Catalyst.

SoftBank and Alexandria Real Estate Equities helped the Bloomberg-backed genetic medicine developer raise series C funding to further expand its pipeline of RNA therapies.

MicroPort's implantable implantable defibrillator and pacemaker spinoff has secured funding in a series C round co-led by its parent company.